Abstract:Several analytical procedures are described in the European Pharmacopoeia (Ph. Eur.) to determine total protein content. However, the method for the determination of protein content in therapeutic immunoglobulins prescribed in the Ph. Eur. monographs is the Kjeldahl method. The Kjeldahl method is time-consuming and requires the use of large amounts of hazardous reagents, which also results in the production of a large amount of hazardous chemical waste. The purpose of this work was to validate an alternative chromatographic method that requires no hazardous reagents and saves time, using the same instrumental conditions specified in the Ph. Eur. for the human immunoglobulin size-exclusion high-performance liquid chromatography (SEC-HPLC) molecular-size distribution assay. The chromatographic separation was achieved with a TSKgel G3000SW (600 × 7.5 mm, 10 µm) column, using an isocratic elution, with detection at 280 nm wavelength. The mobile phase consisted of an aqueous solution of 0.03 M disodium hydrogen phosphate dehydrate, 0.01 M sodium dihydrogen phosphate monohydrate, 0.2 M sodium chloride and 1 mM sodium azide. The protein content of the test samples was determined referring to a standard with a known protein concentration (i.e. Human immunoglobulin (molecular size) Biological Reference Preparation). The method was validated evaluating the characteristics precision and trueness according to the ICH Q2 guideline, and the goodness of linear fit for the signal response was assessed (given for information only). In addition, the equivalence of methods was evaluated with two one-sided t-tests (TOST) analysis with the Kjeldahl method mentioned in Ph. Eur. monographs on therapeutic immunoglobulins, and with Bland-Altman analysis of SEC-HPLC and manufacturers' data (Kjeldahl and biuret methods). The uncertainty of measurement was also calculated in order to evaluate the accuracy and quality of the results, thus facilitating a reliable compliance/non-compliance decision. Based on the outcome, the method is proposed as a suitable and convenient alternative for the determination of protein content in human immunoglobulins.

Collaborative study for the establishment of the human immunoglobulin for electrophoresis Ph. Eur. BRP batch 3

Collaborative study for the establishment of Ph. Eur. Human immunoglobulin for electrophoresis BRP batch 4

High-Throughput Process Development for Recombinant Human Serum Albumin Separation from Pichia Pastoris Broth with Mixed-Mode Chromatography

Binary Adsorption Processes of Albumin and Immunoglobulin on Hydrophobic Charge-Induction Resins

Collaborative Study for the Calibration of the Ph.Eur. Prekallikrein Activator in Albumin Biological Reference Preparation batches 8, 9 and 10

Validation and application of a SEC-HPLC method for the determination of total protein in therapeutic immunoglobulins as an alternative to the European Pharmacopoeia methods

The Influence of Ionic Strength and pH on Mixed-mode Chromatography for the Isolation of Immunoglobulin G

Isolation And Purification Of Immunoglobulin G From Bovine Colostrums By Hydrophobic Charge-Induction Chromatography

Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay

Commutability evaluation of candidate reference materials and ERM‐DA470k/IFCC for immunoglobulin M using two international approaches

European Concerted Action on Anticoagulation (ECAA) - The Multicentre Calibration of Rabbit and Human ECAA Reference Thromboplastins

Determination of IgG in Human Serum by Solid Substrate Room Temperature Phosphorescence-Immunoassay

Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research

Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research

Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches

Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities

Interlaboratory method validation of imaged capillary isoelectric focusing methodology for analysis of recombinant human erythropoietin.

Standards for total serum protein assays--a collaborative study

Comparative Analysis of Laboratory-Scale Immunoglobulin G Purification Methods from Human Serum

Enhancing affinity purification of monoclonal antibodies from human serum for subsequent CZE-MS analysis

Development, manufacturing and characterization of a highly purified, liquid immunoglobulin g preparation from human plasma